Search for: "U.S. v. Treat"
Results 21 - 40
of 10,874
Sorted by Relevance
|
Sort by Date
19 Nov 2018, 9:49 pm
By Donald Zuhn –- Last month, in FWP IP ApS v. [read post]
3 Dec 2012, 6:00 am
U.S. v. [read post]
3 May 2010, 9:25 pm
By Andrew Williams -- Last week, in ALZA Corp. v. [read post]
24 May 2010, 9:59 pm
By Donald Zuhn -- Last month, in Vanderbilt Univ v. [read post]
15 Apr 2010, 9:59 pm
By Donald Zuhn -- On April 6, the Federal Circuit, in MedPointe Healthcare, Inc. v. [read post]
14 Jul 2011, 7:02 am
So I was interested to see an 11th U.S. [read post]
28 Jan 2007, 9:33 am
Teleflex, IPBiz suggests that the teaching-motivation-suggestion test may be treated like the "general acceptance" test was treated in Daubert v. [read post]
27 Nov 2023, 9:10 pm
The case arose in an IPR over U.S. [read post]
16 Jun 2024, 9:28 pm
The litigation arose over the generic drugmakers' ANDA filings involving Forest Laboratories' Bystolic (nebivolol hydrochloride) product, which is a beta blocker used for treating high blood pressure: The patent asserted in the litigation was U.S. [read post]
4 Sep 2014, 9:59 pm
By Donald Zuhn -- Last month, in AbbVie Inc. v. [read post]
27 Jun 2017, 1:14 pm
Three decades ago, in McCleskey v. [read post]
2 Jun 2014, 9:15 pm
Tweet Tags: constitutional law, international law, Supreme CourtCourt decides Bond v. [read post]
15 Aug 2015, 1:03 pm
Her federal lawsuit, Cook v. [read post]
28 Feb 2008, 5:23 am
In 7-2 decision, U.S. [read post]
17 Jul 2008, 4:23 am
At issue were Merck's Orange Book-listed patents for Fosamax ®, including U.S. [read post]
22 Oct 2018, 3:21 am
The U.S. [read post]
21 Aug 2022, 9:11 pm
Par Orange Book-listed U.S. [read post]
4 Jan 2022, 8:39 pm
The case arose in ANDA litigation over U.S. [read post]
21 Jun 2022, 9:46 pm
To recap, the case arose in ANDA litigation over U.S. [read post]
9 Jul 2018, 8:51 pm
Bahr, Deputy Commissioner for Patent Examination Policy at the U.S. [read post]